Pasithea Therapeutics (KTTA) Balance Sheet: Assets & Liabilities

Pasithea Therapeutics (KTTA) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), Pasithea Therapeutics reported total assets of $60.24M and total liabilities of $5.02M. Shareholders' equity was $55.22M, up 273.5% from $14.78M a year earlier. Total debt stood at $0.00 against $55.16M in cash and short-term investments, a net cash position of $55.16M. That puts debt-to-equity at 0.00, compared with 0.00 a year earlier.

Pasithea Therapeutics Balance Sheet Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Pasithea Therapeutics Corp. (KTTA) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Current Assets
Cash and Cash Equivalents	55.16	6.92	16.33	33.09	52.97	0.24
Cash & Short-Term Investments	55.16	6.92	16.33	33.09	52.97	0.24
Accounts Receivable	0.00	0.00	0.04	0.00	0.00	0.00
Inventory	0.00	0.00	0.00	0.00	0.00	0.00
Other Current Assets	1.20	0.45	0.10	0.99	0.33	0.00
Total Current Assets	56.46	7.37	16.69	34.08	53.30	0.25
Non-Current Assets
Property, Plant & Equipment (Net)	0.00	0.12	0.22	0.63	0.02	0.00
Goodwill	0.00	1.26	1.26	1.26	0.00	0.00
Intangible Assets	3.78	7.31	7.94	8.57	0.00	0.00
Other Non-Current Assets	0.00	0.00	0.00	0.64	0.00	0.00
Total Non-Current Assets	3.78	8.70	9.42	11.10	0.02	0.00
Total Assets	60.24	16.06	26.12	45.18	53.32	0.25
Current Liabilities
Accounts Payable	1.13	1.12	2.55	1.48	0.45	0.01
Short-Term Debt	0.00	0.00	0.08	0.16	0.00	0.00
Other Current Liabilities	3.84	1.12	2.55	0.24	0.45	0.00
Total Current Liabilities	4.97	1.12	2.63	1.88	0.45	0.01
Non-Current Liabilities
Long-Term Debt	0.00	0.00	0.00	0.34	0.00	0.00
Other Non-Current Liabilities	0.05	0.16	0.08	0.46	1.45	0.00
Total Non-Current Liabilities	0.05	0.16	0.08	0.80	1.45	0.00
Total Liabilities	5.02	1.28	2.72	2.68	1.90	0.01
Stockholders' Equity
Common Stock	0.00	0.00	0.00	0.00	0.02	0.01
Retained Earnings	-70.01	-49.58	-35.32	-19.36	-2.21	-0.04
Accumulated Other Comprehensive Income	0.02	-0.01	0.00	0.00	-0.01	0.00
Additional Paid-in Capital	125.21	64.37	58.72	61.86	53.63	0.27
Shares Outstanding	23.09	1.39	1.04	1.30	1.15	-
Total Stockholders' Equity	55.22	14.78	23.40	42.50	51.42	0.24
Total Liabilities & Equity	60.24	16.06	26.12	45.18	53.32	0.25

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Pasithea Therapeutics Balance Sheet

How much debt does Pasithea Therapeutics have?

Pasithea Therapeutics had total debt of $0.00 as of Dec 31, 2025, against $55.16M in cash and short-term investments. Its debt-to-equity ratio was 0.00. Total debt was $0.00 a year earlier.

What are Pasithea Therapeutics's total assets?

Pasithea Therapeutics reported total assets of $60.24M as of Dec 31, 2025, up 275.0% from $16.06M a year earlier. Total liabilities were $5.02M.

What is Pasithea Therapeutics's shareholders' equity?

Pasithea Therapeutics's shareholders' equity was $55.22M as of Dec 31, 2025, or about $2.39 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition